Minster Supplementation with Chondroitin and Glucosamine Shown to Reduce Overall and Cardiovascular Disease Risk of Death

December 22, 2020

Heard of chrondroitin sulfate? Glucosamine sulfate? What about arthritis, disc disease, and heart disease? Today’s Minster chiropractic patients have. Glucosamine and chondroitin’s benefits – natural compounds found in cartilage - have escalated to the level of common knowledge, making their combination supplements very popular for disc and joint issues and now for cardiovascular disease and overall mortality reduction. That is some news! Minster Chiropractic Center is happy to share the additional benefits of glucosamine/chondroitin supplementation.

GLUCOSAMINE USE REDUCED RISK OF DEATH FROM CANCER AND RESPIRATORY DISEASE

A 2012 study of 77,510 Washington (US) state residents in the 50 to 76-year-old range who took glucosamine/chondroitin supplements were involved. They started the study in 2000-2002 and followed up in 2008. Researchers found that current use of glucosamine significantly decreased the risk of death from cancer. Further, a large risk of death decrease due to respiratory disease was noted. (1) Minster chiropractic patients may not have realized that.

GLUCOSAMINE USE REDUCED RISKS OF CARDIOVASCULAR DISEASES

Further, a study of 466,039 glucosamine-taking participants (initiated in 2006-2010 and followed up in 2016) exposed that habitual use of glucosamine to relieve osteoarthritis pain also may lead to lessened risks of cardiovascular issues like stroke, coronary heart disease, and cardiovascular disease death. (2) Minster Chiropractic Center appreciates the expanding list of benefits for glucosamine use.

GS/CS SUPPLEMENTATION REDUCED OVERALL MORTALITY AND CARDIOVASCULAR MORTALITY

Then, these previously published papers grabbed the attention of Dana King, MD, an avid bicyclist who had taken glucosamine/chondroitin for arthritis and found many bicycling friends did as well. (3) She and colleagues further studied this topic and published its results in the Journal of the American Board of Family Medicine. Benefits of glucosamine/chondroitin supplementation and mortality – overall mortality and cardiovascular mortality – are listed. The findings further support the 2012 and 2019 papers just shared. 16,686 US participants were tracked in the National Health and Nutrition Examination Study from 1999 to 2010. 658 of them had been taking glucosamine/chondroitin for at least 12 months. These participants were found to be less prone to die due to cardiovascular disease issues by 65% and less likely to die due to overall/all-cause issues by 39%. (4) Minster Chiropractic Center surely knows the benefit of glucosamine/chondroitin for cartilage related conditions like osteoarthritis, disc disease, and joint pain and is inspired to see its benefit spread beyond these issues for our Minster chiropractic patients.

SUPPLEMENTATION NOT SUBSTITUTION

Interviewed for the journal, Bicycling, lead researcher in the 2020 paper, Dr. King dubs the results “encouraging” but adds that taking supplements is not a substitute for exercise but their addition is apparently beneficial from an epidemiological standpoint. (3) Minster Chiropractic Center agrees! Chiropractic care combines spinal manipulation, nutrition, and exercise to improve positive clinical outcomes for pain relief and quality of life. Listen to this PODCAST with Dr. James Cox on The Back Doctors Podcast with Dr. Michael Johnson as he describes how The Cox® Technic System of Spinal Pain Management integrates nutrition like glucosamine/chondroitin for optimal clinical outcomes.

CONTACT Minster Chiropractic Center

Make your Minster chiropractic appointment now. Surely this data on the benefits of glucosamine/chondroitin supplementation piqued your interest whether you have disc/joint/osteoarthritis issues or cardiovascular issues. Minster Chiropractic Center is here to talk about it further!

 
Minster Chiropractic Center presents new research supporting the habitual use of chondroitin and glucosamine which is shown to reduce overall and cardiovascular disease mortality.